Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.

MLA

Chaukar, Devendra, et al. “Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 3, Jan. 2022, pp. 272–81. EBSCOhost, https://doi.org/10.1200/JCO.21.00179.

APA

Chaukar, D., Prabash, K., Rane, P., Patil, V. M., Thiagarajan, S., Ghosh-Laskar, S., Sharma, S., Pai, P. S., Chaturvedi, P., Pantvaidya, G., Deshmukh, A., Nair, D., Nair, S., Vaish, R., Noronha, V., Patil, A., Arya, S., & D’Cruz, A. (2022). Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 40(3), 272–281. https://doi.org/10.1200/JCO.21.00179

Chicago

Chaukar, Devendra, Kumar Prabash, Pawan Rane, Vijay Maruti Patil, Shivakumar Thiagarajan, Sarbani Ghosh-Laskar, Shilpi Sharma, et al. 2022. “Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40 (3): 272–81. doi:10.1200/JCO.21.00179.